logo dark logo light logo
  • 首页
  • 关于我们
    • 背景
    • 投资战略
    • 团队
  • 投资组合
  • 新闻中心
  • 联系我们
  • English
  • 投资者登录
mobile-logo
  • 首页
  • 关于我们
    • 背景
    • 投资战略
    • 团队
  • 投资组合
  • 新闻中心
  • 联系我们
  • English
  • 投资者登录
 

新闻中心

05 11月 2019
by admin
in Uncategorized
Comments
Syros to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019
05 11月 2019
by admin
in Uncategorized
Comments
resTORbio Reports Third Quarter 2019 Financial Results and Corporate Update
04 11月 2019
by admin
in Uncategorized
Comments
NextCure to Host and Webcast Event at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting
25 10月 2019
by admin
in Uncategorized
Comments
New Biotechnology publication validates Crescendo Biologics’ platform as it moves towards the clinic
17 10月 2019
by admin
in Uncategorized
Comments
Syros Announces Update on Selective CDK7 Inhibitor Portfolio
07 10月 2019
by admin
in Uncategorized
Comments
Tempest Therapeutics Names Biopharmaceutical Executive Stephen Brady as President and Chief Operating Office
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24

中国上海市浦东新区张江高科技园区金科路4560号金创大厦3号楼8楼,201210
电话: +86 21 6163 2598  |  传真: +86 21 6163 2570  |  邮件: info@quancapital.com

© Quan Capital. All rights reserved. Credit: Website Design